REFERENCES
-
1
Favaloro E J.
Editorial. Welcome to a special issue of Seminars in Thrombosis and Hemostasis—the closing issue for 2008.
Semin Thromb Hemost.
2008;
34
693-696
-
2
Favaloro E J.
A tribute to Eberhard F. Mammen, M.D. (1930–2008).
Semin Thromb Hemost.
2008;
34(8)
703-707
-
3
Favaloro E J.
Editorial. Welcome to the first issue of Seminars in Thrombosis and Hemostasis for 2009.
Semin Thromb Hemost.
2009;
35
1-2
-
4
Girolami B, Girolami A.
Heparin-induced thrombocytopenia: a review.
Semin Thromb Hemost.
2006;
32(8)
803-809
-
5
Jurk K, Kehrel B E.
Platelets: physiology and biochemistry.
Semin Thromb Hemost.
2005;
31(4)
381-392
-
6
Pini M, Spyropoulos A C.
Prevention of venous thromboembolism.
Semin Thromb Hemost.
2006;
32(8)
755-766
-
7
Tiu R V, Mountantonakis S E, Dunbar A J, Schreiber Jr M J.
Tumor lysis syndrome.
Semin Thromb Hemost.
2007;
33(4)
397-407
-
8
Prechel M, Walenga J M.
The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.
Semin Thromb Hemost.
2008;
34(1)
86-96
-
9
Harenberg J, Wehling M.
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa.
Semin Thromb Hemost.
2008;
34(1)
39-57
-
10
Laux V, Perzborn E, Kubitza D, Misselwitz F.
Preclinical and clinical characteristics of rivaroxaban: a novel, oral, direct factor Xa inhibitor.
Semin Thromb Hemost.
2007;
33(5)
515-523
-
11
Kucher N, Goldhaber S Z.
Risk stratification of acute pulmonary embolism.
Semin Thromb Hemost.
2006;
32
838-847
-
12
Cohn D M, Roshani S, Middeldorp S.
Thrombophilia and venous thromboembolism: implications for testing.
Semin Thromb Hemost.
2007;
33(6)
573-581
-
13
Esmon C T.
Inflammation and the activated protein C anticoagulant pathway.
Semin Thromb Hemost.
2006;
32(Suppl 1)
49-60
-
14
Ho V T, Linden E, Revta C, Richardson P G.
Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: review and update on the use of defibrotide.
Semin Thromb Hemost.
2007;
33(4)
373-388
-
15
Ageno W, Squizzato A, Garcia D, Imberti D.
Epidemiology and risk factors of venous thromboembolism.
Semin Thromb Hemost.
2006;
32(7)
651-658
-
16
Fareed J, Hoppensteadt D A, Fareed D et al..
Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Semin Thromb Hemost.
2008;
34(1)
58-73
-
17
Bernardi E, Pesavento R, Prandoni P.
Upper extremity deep venous thrombosis.
Semin Thromb Hemost.
2006;
32(7)
729-736
-
18
Blum W, Porcu P.
Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome.
Semin Thromb Hemost.
2007;
33(4)
350-354
-
19
Boekholdt S M, Kramer M H.
Arterial thrombosis and the role of thrombophilia.
Semin Thromb Hemost.
2007;
33(6)
588-596
-
20
Michiels J J, De Raeve H, Berneman Z et al..
The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Semin Thromb Hemost.
2006;
32(4 Pt 2)
307-340
-
21
Tefferi A, Elliott M.
Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F.
Semin Thromb Hemost.
2007;
33(4)
313-320
-
22
Siegel-Axel D I, Gawaz M.
Platelets and endothelial cells.
Semin Thromb Hemost.
2007;
33(2)
128-135
-
23
Stellos K, Gawaz M.
Platelets and stromal cell-derived factor-1 in progenitor cell recruitment.
Semin Thromb Hemost.
2007;
33(2)
159-164
-
24
Enjeti A K, Lincz L F, Seldon M.
Detection and measurement of microparticles: an evolving research tool for vascular biology.
Semin Thromb Hemost.
2007;
33
771-779
-
25
Middeldorp S, Levi M.
Thrombophilia: an update.
Semin Thromb Hemost.
2007;
33(6)
563-572
-
26
Zakarija A, Bennett C.
Drug-induced thrombotic microangiopathy.
Semin Thromb Hemost.
2005;
31(6)
681-690
-
27
De Stefano V, Rossi E, Za T, Leone G.
Prophylaxis and treatment of venous thromboembolism in individuals with inherited thrombophilia.
Semin Thromb Hemost.
2006;
32(8)
767-780
-
28
Davie E W, Kulman J D.
An overview of the structure and function of thrombin.
Semin Thromb Hemost.
2006;
32(Suppl 1)
3-15
-
29
Favaloro E J.
Measuring the quality of journals and journal articles: the impact factor tells but a portion of the story.
Semin Thromb Hemost.
2008;
34(1)
7-25
Emmanuel J FavaloroPh.D. M.A.I.M.S.
Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR)
Westmead Hospital, WSAHS, Westmead, Australia
